ABP-008

N/A

Report date: 2025/01/26 15:12:17
NME

Base Information

Drug NameABP-008
Drug Alias Nameselective estrogen receptor modulator-hyaluronic acid complex (Aluron Biopharama)ABP-008
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptor alpha modulators
TargetsEstrogen receptor alpha
Therapy Area/IndicationsOsteoporosis, PostmenopausalBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAluron Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAluron Biopharma Inc
Inactive CompaniesN/A
Active IndicationsOsteoporosis, PostmenopausalBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A